[en] Background & aims: Binge eating disorder (BED) is a frequent eating disorder associated with obesity and co-morbidities including psychiatric pathologies, which represent a big health burden on the society. The biological processes related to BED remain unknown. Based on psychological testing, anthropometry, clinical biology, gut microbiota analysis and metabolomic assessment, we aimed to examine the complex biological and psychiatric profile of obese patients with and without BED.
Methods: Psychological and biological characteristics (anthropometry, plasma biology, gut microbiota, blood pressure) of 101 obese subjects from the Food4Gut cohort were analysed to decipher the differences between BED and Non BED patients, classified based on the Questionnaire for Eating Disorder Diagnosis (Q-EDD). Microbial 16S rDNA sequencing and plasma non-targeted metabolomics (liquid chromatography-mass spectrometry) were performed in a subcohort of 91 and 39 patients respectively.
Results: BED subjects exhibited an impaired affect balance, deficits in inhibition and self-regulation together with marked alterations of eating behaviour (increased emotional and external eating). BED subjects displayed a lower blood pressure and hip circumference. A decrease in Akkermansia and Intestimonas as well as an increase in Bifidobacterium and Anaerostipes characterized BED subjects. Interestingly, metabolomics analysis revealed that BED subjects displayed a higher level of one food contaminants, Bisphenol A bis(2,3-dihydroxypropyl) ether (BADGE.2H(2)O) and a food derived-metabolite the Isovalerylcarnitine.
Conclusions: Non-targeted omics approaches allow to select specific microbial genera and two plasma metabolites that characterize BED obese patients. Further studies are needed to confirm their potential role as drivers or biomarkers of binge eating disorder.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
LEYROLLE, QUENTIN
Cserjesi, Renata
Mulders, Maria
Zamariola, Giorgia
Hiel, Sophie
Gianfrancesco, Marco ; Université de Liège - ULiège > Département des sciences fonctionnelles (DSF) > Biochimie et biologie moléculaire
Rodriguez, Julie
Paquot, Nicolas ; Université de Liège - ULiège > Département des sciences de la santé publique > Diabétologie, nutrition et maladies métaboliques
DELZENNE, Nathalie
Language :
English
Title :
Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients
Hay, P., Girosi, F., Mond, J., Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population. J Eat Disord, 3, 2015, 19.
Galmiche, M., Déchelotte, P., Lambert, G., Tavolacci, M.P., Prevalence of eating disorders over the 2000-2018 period: a systematic literature review. Am J Clin Nutr 109:5 (01 2019), 1402–1413.
Vamado, P.J., Williamson, D.A., Bentz, B.G., Ryan, D.H., Rhodes, S.K., O'Neil, P.M., et al. Prevalence of binge eating disorder in obese adults seeking weight loss treatment. Eat Weight Disord 2:3 (sept 1997), 117–124.
Pasold, T.L., McCracken, A., Ward-Begnoche, W.L., Binge eating in obese adolescents: emotional and behavioral characteristics and impact on health-related quality of life. Clin Child Psychol Psychiatr 19:2 (avr 2014), 299–312.
Fairburn, C.G., Doll, H.A., Welch, S.L., Hay, P.J., Davies, B.A., O'Connor, M.E., Risk factors for binge eating disorder: a community-based, case-control study. Arch Gen Psychiatr 55:5 (mai 1998), 425–432.
Stice, E., Risk and maintenance factors for eating pathology: a meta-analytic review. Psychol Bull 128:5 (sept 2002), 825–848.
Bakalar, J.L., Shank, L.M., Vannucci, A., Radin, R.M., Tanofsky-Kraff, M., Recent advances in developmental and risk factor research on eating disorders. Curr Psychiatr Rep, 17(6), juin 2015, 42.
Ferrario, C.R., Labouèbe, G., Liu, S., Nieh, E.H., Routh, V.H., Xu, S., et al. Homeostasis meets motivation in the battle to control food intake. J Neurosci 36:45 (9 nov 2016), 11469–11481.
Capuron, L., Poitou, C., Machaux-Tholliez, D., Frochot, V., Bouillot, J.-L., Basdevant, A., et al. Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychol Med 41:7 (juill 2011), 1517–1528.
Valdearcos, M., Robblee, M.M., Benjamin, D.I., Nomura, D.K., Xu, A.W., Koliwad, S.K., Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell Rep 9:6 (déc 2014), 2124–2138.
Challet, E., The circadian regulation of food intake. Nat Rev Endocrinol 15:7 (juill 2019), 393–405.
Visconti, A., Le Roy, C.I., Rosa, F., Rossi, N., Martin, T.C., Mohney, R.P., et al. Interplay between the human gut microbiome and host metabolism. Nat Commun 10:1 (3 oct 2019), 1–10.
Cryan, J.F., O'Riordan, K.J., Cowan, C.S.M., Sandhu, K.V., Bastiaanssen, T.F.S., Boehme, M., et al. The microbiota-gut-brain Axis. Physiol Rev 99:4 (01 2019), 1877–2013.
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555:7695 (mars 2018), 210–215.
Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16:6 (27 mai 2016), 341–352.
Bonaz, B., Bazin, T., Pellissier, S., The vagus nerve at the interface of the microbiota-gut-brain Axis. [cité 27 avr 2020] Front Neurosci, 12, 7 févr 2018 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808284/.
Dumas, M.-E., Rothwell, A.R., Hoyles, L., Aranias, T., Chilloux, J., Calderari, S., et al. Microbial-host Co-metabolites are prodromal markers predicting phenotypic heterogeneity in behavior, obesity, and impaired glucose tolerance. Cell Rep 20:1 (5 juill 2017), 136–148.
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med 24:7 (2018), 1070–1080.
Hiel, S., Gianfrancesco, M.A., Rodriguez, J., Portheault, D., Leyrolle, Q., Bindels, L.B., et al. Link between gut microbiota and health outcomes in inulin -treated obese patients: lessons from the Food4Gut multicenter randomized placebo-controlled trial. Clin Nutr 39:12 (13 avr 2020), 3618–3628 Disponible sur: https://www.clinicalnutritionjournal.com/article/S0261-5614(20)30160-6/abstract.
Olivares, M., Neyrinck, A.M., Pötgens, S.A., Beaumont, M., Salazar, N., Cani, P.D., et al. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice. Diabetologia 61:8 (2018), 1838–1848.
Pötgens, S.A., Brossel, H., Sboarina, M., Catry, E., Cani, P.D., Neyrinck, A.M., et al. Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Sci Rep, 8(1), 17 2018, 12321.
Klåvus, A., Kokla, M., Noerman, S., Koistinen, V.M., Tuomainen, M., Zarei, I., et al. « notame »: workflow for non-targeted LC-MS metabolic profiling. Metabolites, 10(4), 31 mars 2020.
Tsugawa, H., Cajka, T., Kind, T., Ma, Y., Higgins, B., Ikeda, K., et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods 12:6 (juin 2015), 523–526.
Sumner, L.W., Amberg, A., Barrett, D., Beale, M.H., Beger, R., Daykin, C.A., et al. Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3:3 (sept 2007), 211–221.
Mintz, L.B., O'Halloran, M.S., Mulholland, A.M., Schneider, P.A., Questionnaire for Eating Disorder Diagnoses: reliability and validity of operationalizing DSM—IV criteria into a self-report format. J Counsel Psychol 44:1 (1997), 63–79.
Bailly, N., Maitre, I., Amanda, M., Hervé, C., Alaphilippe, D., The Dutch Eating Behaviour Questionnaire (DEBQ). Assessment of eating behaviour in an aging French population. Appetite 59:3 (1 déc 2012), 853–858.
Brasseur, S., Grégoire, J., Bourdu, R., Mikolajczak, M., The Profile of Emotional Competence (PEC): development and validation of a self-reported measure that fits dimensions of emotional competence theory. PloS One, 8(5), 2013, e62635.
Watson, D., Clark, L.A., Tellegen, A., Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:6 (juin 1988), 1063–1070.
Diener, E., Wirtz, D., Tov, W., Kim-Prieto, C., Choi, D., Oishi, S., et al. New well-being measures: short scales to assess flourishing and positive and negative feelings. Soc Indicat Res 97:2 (1 juin 2010), 143–156.
Miyake, A., Friedman, N.P., Emerson, M.J., Witzki, A.H., Howerter, A., Wager, T.D., The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cognit Psychol 41:1 (août 2000), 49–100.
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46:W1 (02 2018), W486–W494.
Masheb, R.M., Grilo, C.M., Emotional overeating and its associations with eating disorder psychopathology among overweight patients with binge eating disorder. Int J Eat Disord 39:2 (mars 2006), 141–146.
Zeeck, A., Stelzer, N., Linster, H.W., Joos, A., Hartmann, A., Emotion and eating in binge eating disorder and obesity. Eur Eat Disord Rev 19:5 (oct 2011), 426–437.
Pinaquy, S., Chabrol, H., Simon, C., Louvet, J.-P., Barbe, P., Emotional eating, alexithymia, and binge-eating disorder in obese women. Obes Res 11:2 (févr 2003), 195–201.
Escandón-Nagel, N., Peró, M., Grau, A., Soriano, J., Feixas, G., Emotional eating and cognitive conflicts as predictors of binge eating disorder in patients with obesity. Int J Clin Health Psychol 18:1 (1 janv 2018), 52–59.
Córdova, M.E., Schiavon, C.C., Busnello, F.M., Reppold, C.T., Nutritional and neuropsychological profile of the executive functions on binge eating disorder in obese adults. Nutr Hosp 34:5 (17 nov 2017), 1448–1454.
Duchesne, M., Mattos, P., Appolinário, J.C., de Freitas, S.R., Coutinho, G., Santos, C., et al. Assessment of executive functions in obese individuals with binge eating disorder. Br J Psychiatr 32:4 (déc 2010), 381–388.
Blume, M., Schmidt, R., Hilbert, A., Executive functioning in obesity, food addiction, and binge-eating disorder. [cité 19 juin 2020] Nutrients [Internet], 11(1), 28 déc 2018 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356459/.
Murialdo, G., Casu, M., Falchero, M., Brugnolo, A., Patrone, V., Cerro, P.F., et al. Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels. J Endocrinol Invest 30:5 (mai 2007), 356–362.
McElroy, S.L., Hudson, J., Ferreira-Cornwell, M.C., Radewonuk, J., Whitaker, T., Gasior, M., Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology 41:5 (avr 2016), 1251–1260.
Gasior, M., Hudson, J., Quintero, J., Ferreira-Cornwell, M.C., Radewonuk, J., McElroy, S.L., A phase 3, multicenter, open-label, 12-month extension safety and tolerability trial of lisdexamfetamine dimesylate in adults with binge eating disorder. J Clin Psychopharmacol 37:3 (juin 2017), 315–322.
Lukovac, S., Belzer, C., Pellis, L., Keijser, B.J., de Vos, W.M., Montijn, R.C., et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio, 5(4), 12 août 2014.
Rastelli, M., Cani, P.D., Knauf, C., The gut microbiome influences host endocrine functions. Endocr Rev 40:5 (01 2019), 1271–1284.
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110 (28 mai 2013), 9066–9071.
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23 (janv 2017), 107–113.
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25:7 (2019), 1096–1103.
Delzenne, N.M., Neyrinck, A.M., Bäckhed, F., Cani, P.D., Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:11 (9 août 2011), 639–646.
Tamanai-Shacoori, Z., Smida, I., Bousarghin, L., Loreal, O., Meuric, V., Fong, S.B., et al. Roseburia spp.: a marker of health?. Future Microbiol 12 (2017), 157–170.
Kasahara, K., Krautkramer, K.A., Org, E., Romano, K.A., Kerby, R.L., Vivas, E.I., et al. Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol 3:12 (déc 2018), 1461–1471.
Liu, J., An, N., Ma, C., Li, X., Zhang, J., Zhu, W., et al. Correlation analysis of intestinal flora with hypertension. Exp Ther Med 16:3 (sept 2018), 2325–2330.
Kleiman, S.C., Watson, H.J., Bulik-Sullivan, E.C., Huh, E.Y., Tarantino, L.M., Bulik, C.M., et al. The intestinal microbiota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and eating disorder psychopathology. Psychosom Med 77:9 (2015), 969–981.
Cheung, S.G., Goldenthal, A.R., Uhlemann, A.-C., Mann, J.J., Miller, J.M., Sublette, M.E., Systematic review of gut microbiota and major depression. Front Psychiatr, 10, 2019, 34.
Bui, T.P.N., Ritari, J., Boeren, S., de Waard, P., Plugge, C.M., de Vos, W.M., Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat Commun 6:1 (1 déc 2015), 1–10.
Hammarling, L., Gustavsson, H., Svensson, K., Oskarsson, A., Migration of bisphenol-A diglycidyl ether (BADGE) and its reaction products in canned foods. Food Addit Contam 17:11 (nov 2000), 937–943.
Cao, X.-L., Dufresne, G., Clement, G., Bélisle, S., Robichaud, A., Beraldin, F., Levels of bisphenol A diglycidyl ether (BADGE) and bisphenol F diglycidyl ether (BFDGE) in canned liquid infant formula products in Canada and dietary intake estimates. J AOAC Int 92:6 (déc 2009), 1780–1789.
Marqueño, A., Pérez-Albaladejo, E., Flores, C., Moyano, E., Porte, C., Toxic effects of bisphenol A diglycidyl ether and derivatives in human placental cells. Environ Pollut 244 (1 janv 2019), 513–521.
Ahn, S.-W., Nedumaran, B., Xie, Y., Kim, D.-K., Kim, Y.D., Choi, H.-S., Bisphenol A bis(2,3-dihydroxypropyl) ether (BADGE.2H2O) induces orphan nuclear receptor Nur77 gene expression and increases steroidogenesis in mouse testicular Leydig cells. Mol Cell 26:1 (31 juill 2008), 74–80.
Gilbert, F., Morissette, M., St-Hilaire, M., Paquet, B., Rouillard, C., Di Paolo, T., et al. Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatr 60:6 (15 sept 2006), 538–547.
Chen, Y., Wu, R., Chen, H.-Z., Xiao, Q., Wang, W.-J., He, J.-P., et al. Enhancement of hypothalamic STAT3 acetylation by nuclear receptor Nur77 dictates leptin sensitivity. Diabetes 64:6 (juin 2015), 2069–2081.
Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabol 9:4 (avr 2009), 311–326.
Butte, N.F., Liu, Y., Zakeri, I.F., Mohney, R.P., Mehta, N., Voruganti, V.S., et al. Global metabolomic profiling targeting childhood obesity in the Hispanic population12. Am J Clin Nutr 102:2 (août 2015), 256–267.
Kukharenko, A., Brito, A., Kozhevnikova, M.V., Moskaleva, N., Markin, P.A., Bochkareva, N., et al. Relationship between the plasma acylcarnitine profile and cardiometabolic risk factors in adults diagnosed with cardiovascular diseases. Clin Chim Acta 507 (1 août 2020), 250–256.
Liu, X., Zheng, P., Zhao, X., Zhang, Y., Hu, C., Li, J., et al. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res 14:5 (1 mai 2015), 2322–2330.
Nasca, C., Bigio, B., Lee, F.S., Young, S.P., Kautz, M.M., Albright, A., et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci USA 115:34 (21 2018), 8627–8632.
Bhattacharyya, S., Dunlop, B.W., Mahmoudiandehkordi, S., Ahmed, A.T., Louie, G., Frye, M.A., et al. Pilot study of metabolomic clusters as state markers of major depression and outcomes to CBT treatment. [cité 16 juin 2020] Front Neurosci, 13, 12 sept 2019 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751322/.
Tasic, L., Larcerda, A.L.T., Pontes, J.G.M., da Costa, T.B.B.C., Nani, J.V., Martins, L.G., et al. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder. J Psychiatr Res 119 (1 déc 2019), 67–75.
Frye, R.E., Vassall, S., Kaur, G., Lewis, C., Karim, M., Rossignol, D., Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med, 7(23), 27 nov 2019, 792.
Vockley, J., Ensenauer, R., Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142C:2 (15 mai 2006), 95–103.
Szczesniak, O., Hestad, K.A., Hanssen, J.F., Rudi, K., Isovaleric acid in stool correlates with human depression. Nutr Neurosci 19:7 (sept 2016), 279–283.
Keane, P.E., Morre, M., Effect of valproate on brain GABA: comparison with various medium chain fatty acids. Pharmacol Res Commun 17:6 (1 juin 1985), 547–555.
Bellono, N.W., Bayrer, J.R., Leitch, D.B., Castro, J., Zhang, C., O'Donnell, T., et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170:1 (29 juin 2017), 185–198 e16.
Flanagan, J.L., Simmons, P.A., Vehige, J., Willcox, M.D., Garrett, Q., Role of carnitine in disease. Nutr Metab, 7, 16 avr 2010, 30.
Manji, H., Kato, T., Di Prospero, N.A., Ness, S., Beal, M.F., Krams, M., et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13:5 (mai 2012), 293–307.
Picard, M., McEwen, B.S., Epel, E.S., Sandi, C., An energetic view of stress: focus on mitochondria. Front Neuroendocrinol 49 (2018), 72–85.
Penninx, B.W.J.H., Lange, S.M.M., Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci 20:1 (mars 2018), 63–73.